On the other hand, a study by Jury et al. indicates that increasing serum levels of S100 protein serves as a precise and sensitive marker that is clinically significant for monitoring tumor progression in melanoma patients, often appearing before other signs of disease recurrence [39]. The gene discussed is S100B; the disease is neoplasm.